Gut health is one of the most-searched topics in UK pharmacy retail, and the two categories customers most often confuse are prebiotics and probiotics. They sit together on the shelf, they both come in capsule form, and the marketing bleeds between them. But they do different things, and evidence for specific uses varies sharply between products.
The simple definition
A probiotic is a live microorganism that, when taken in adequate amounts, confers a health benefit on the host. The common genera on UK shelves are Lactobacillus, Bifidobacterium and Saccharomyces boulardii (a yeast).
A prebiotic is a non-digestible carbohydrate selectively fermented by beneficial gut bacteria. The common prebiotics on UK shelves are inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS) and partially hydrolysed guar gum (PHGG).
A synbiotic combines both — for example, a capsule with Bifidobacterium longum plus inulin.
What probiotics have evidence for
The honest pharmacy answer is: some strains, for some indications, at defined doses. Generic "probiotic" capsules marketed for general wellbeing have little clinical evidence. The specific uses with reasonable evidence, all summarised in Cochrane reviews or equivalent:
| Indication | Strain with strongest evidence | Typical dose |
|---|---|---|
| Antibiotic-associated diarrhoea | Saccharomyces boulardii, L. rhamnosus GG | 1–4 × 10⁹ CFU/day during and 1 week after antibiotics |
| Acute infectious gastroenteritis (children) | S. boulardii, L. rhamnosus GG | 1 × 10⁹ CFU/day for 5 days |
| Traveller's diarrhoea prevention | S. boulardii | 500 mg daily before and during travel |
| IBS (overall symptoms, mixed evidence) | Various multi-strain | 1–10 × 10⁹ CFU/day for ≥4 weeks |
| Eczema in infants at high risk | Specific Lactobacillus strains during pregnancy | Not OTC |
NICE CKS on irritable bowel syndrome states that "some people find probiotics helpful" and recommends a 4-week trial at the dose recommended by the manufacturer before stopping if no benefit. NICE does not specify strains — this is a reasonable counter framework.
What prebiotics have evidence for
Prebiotics feed beneficial bacteria rather than introducing new ones. Evidence tends to be more indication-specific than for probiotics.
- Inulin and FOS: Modest increase in Bifidobacterium abundance. Can cause significant bloating, flatulence and abdominal pain at doses above 5 g/day, and are generally poorly tolerated by IBS patients — where they are often excluded on low-FODMAP diets.
- Partially hydrolysed guar gum (PHGG): Better tolerated than inulin in IBS, with trials showing modest symptom improvement. A 2021 systematic review reported benefits on constipation-predominant and mixed IBS over 4–12 weeks at 5 g/day.
- GOS: Limited OTC presence in the UK; main evidence is in infant formula.
The clinical takeaway: for IBS, inulin often makes symptoms worse and PHGG is a better option. For general gut wellness without GI symptoms, dietary fibre from food remains the better-evidence choice than capsule prebiotics.
The IBS conversation specifically
IBS is the single most common reason customers ask about prebiotics and probiotics in community pharmacy. Three practical points:
- Rule out red flags — age over 50 at onset, unintended weight loss, rectal bleeding, nocturnal diarrhoea, family history of bowel cancer or IBD. Refer if present.
- NICE recommends a trial of probiotics for 4 weeks as part of stepped self-care. If no benefit, stop.
- Prebiotics are divisive in IBS. High-FODMAP prebiotics (inulin, FOS) frequently worsen symptoms. PHGG is low-FODMAP and usually well tolerated. Always ask about symptom pattern before recommending.
Safety
Probiotics and prebiotics are safe in the overwhelming majority of healthy adults. Specific cautions:
| Situation | Note |
|---|---|
| Immunosuppression | Avoid live probiotics — rare bloodstream infections reported with Lactobacillus in severely immunocompromised patients |
| Central venous catheters | Avoid Saccharomyces — fungaemia case reports |
| Acute pancreatitis | Do not use probiotics — increased mortality in one critical care trial |
| Pregnancy | Generally considered safe; evidence for specific strains in atopy prevention is limited |
| Infants | Only strain-specific products studied in infants; general OTC products not for <1 year |
Reading the label
A pharmacy-useful label shows:
- Genus, species and strain (e.g. Lactobacillus rhamnosus GG ATCC 53103). "Lactobacillus blend" is not enough.
- CFU count at end of shelf life, not at manufacture. A product guaranteed 1 × 10⁹ CFU at expiry is more reliable than one guaranteed at production.
- Storage requirements — many strains require refrigeration.
- Dose per capsule and regimen.
Products that claim benefits without identifying strains, or that mix 20+ strains at vanishingly small CFU counts each, are unlikely to match clinical trial evidence and are not worth a specific recommendation.
Where this sits in UK pharmacy
Gut symptoms drive an increasing share of self-care conversations in community pharmacy, and the prebiotic/probiotic section is often where customers land first. PharmSee's pharmacy directory lists the UK network providing evidence-based gut health counselling, and our clinical pharmacy jobs reflect rising employer demand for pharmacists confident across this category.
Caveats
This article summarises NICE CG61 and CKS guidance, British Dietetic Association position and a selection of Cochrane reviews as of April 2026. Product formulations change regularly and specific-strain evidence should be re-checked if counselling on a particular product. As always, red-flag symptoms require GP referral regardless of supplementation.